← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2016Last known activity
Jun 8, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06690723Lead sponsorPhase 3Jun 8, 2022
- NCT04654676Lead sponsorPhase 4Sep 15, 2018
- NCT04462016Lead sponsorN/AFeb 2, 2018
- NCT04462016Overall official - principal investigatorN/AFeb 2, 2018
- NCT03459599CollaboratorN/AOct 1, 2016
Details
- Last known activity
- Jun 8, 2022